{"id":"https://openalex.org/W4388047669","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0864","title":"864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation","display_name":"864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388047669","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0864"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0864","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0864","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0864","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/964.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/964.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113033856","display_name":"Avijit Goswami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Avijit Goswami","raw_affiliation_strings":["Aten Porus Lifesciences, Pvt., Ltd., Bangalore, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aten Porus Lifesciences, Pvt., Ltd., Bangalore, Karnataka, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049544741","display_name":"Sandeep Goyal","orcid":"https://orcid.org/0000-0001-6915-9835","observed_orcids":["https://orcid.org/0000-0001-6915-9835"]},"institutions":[{"id":"https://openalex.org/I4210139967","display_name":"Atossa Therapeutics (United States)","ror":"https://ror.org/03yqekx34","country_code":"US","type":"company","lineage":["https://openalex.org/I4210139967"]},{"id":"https://openalex.org/I4210155800","display_name":"Levin Institute","ror":"https://ror.org/05gb36730","country_code":"US","type":"education","lineage":["https://openalex.org/I4210155800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandeep Goyal","raw_affiliation_strings":["Aten Porus Lifesciences, Levittown, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aten Porus Lifesciences, Levittown, PA, USA","institution_ids":["https://openalex.org/I4210139967","https://openalex.org/I4210155800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055347652","display_name":"Princy Khurana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Princy Khurana","raw_affiliation_strings":["Avammune Therapeutics, Inc., Levittown, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avammune Therapeutics, Inc., Levittown, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102244161","display_name":"Kawaljit Singh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kawaljit Singh","raw_affiliation_strings":["Avammune Therapeutics, Inc., Levittown, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avammune Therapeutics, Inc., Levittown, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070948417","display_name":"Ishani Ghoshal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ishani Ghoshal","raw_affiliation_strings":["Aten Porus Lifesciences, Pvt., Ltd., Bangalore, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aten Porus Lifesciences, Pvt., Ltd., Bangalore, Karnataka, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009137011","display_name":"Aditya Kulkarni","orcid":"https://orcid.org/0000-0002-7084-428X","observed_orcids":["https://orcid.org/0000-0002-7084-428X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aditya Kulkarni","raw_affiliation_strings":["Avammune Therapeutics, Inc., Levittown, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avammune Therapeutics, Inc., Levittown, PA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A963","last_page":"A963"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.3962000012397766,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.3962000012397766,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.2538999915122986,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.20839999616146088,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cgas-sting-pathway","display_name":"cGAS-STING pathway","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7059999704360962},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7879999876022339},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.699999988079071},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.753000020980835},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.828000009059906},{"id":"https://openalex.org/keywords/adenosine","display_name":"adenosine","score":0.6340000033378601},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.6230000257492065},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.47099998593330383},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.3149999976158142}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6703716516494751},{"id":"https://openalex.org/C2779300339","wikidata":"https://www.wikidata.org/wiki/Q7617409","display_name":"Sting","level":2,"score":0.6548707485198975},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5672105550765991},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.508878231048584},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4782922863960266},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4469600021839142},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4205259382724762},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27938228845596313},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1837368607521057},{"id":"https://openalex.org/C146978453","wikidata":"https://www.wikidata.org/wiki/Q3798668","display_name":"Aerospace engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0864","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0864","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0864","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/964.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:38669d3ee8534a4b8b0bac1a028fc6cf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/38669d3ee8534a4b8b0bac1a028fc6cf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0864","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0864","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0864","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/964.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388047669.pdf","grobid_xml":"https://content.openalex.org/works/W4388047669.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388089593","https://openalex.org/W4362592252","https://openalex.org/W4308394516","https://openalex.org/W4409690269","https://openalex.org/W4308402608","https://openalex.org/W4388042424","https://openalex.org/W4362597326","https://openalex.org/W4303959019","https://openalex.org/W4307910490","https://openalex.org/W4415900216"],"abstract_inverted_index":{"Background":[0],"STING":[1,72,77],"agonists":[2],"have":[3,93,252],"become":[4],"an":[5,123,244],"attractive":[6],"immunomodulatory":[7],"approach":[8],"to":[9,43,269],"activate":[10],"the":[11,22,45,53,60,114,320,388,406],"cGAS-STING":[12,46,61,115],"pathway":[13,47,62],"for":[14,40,48,143,208,301,387],"turning":[15],"cold":[16],"tumors":[17,82,86],"hot":[18],"and":[19,74,87,91,105,161,177,183,219,259,271,288,303,307,334,343,354,376],"thereby":[20,242],"improving":[21],"efficacy":[23,164,293,370],"of":[24,52,59,149,165,186,202,283,294,348,371,391],"Immune":[25],"Checkpoint":[26],"Inhibitors":[27],"(ICI).":[28],"However,":[29],"considering":[30],"their":[31,312],"modest":[32],"clinical":[33],"efficacy,":[34],"there":[35],"is":[36,63,131],"a":[37,56,99,132,217,274,384],"substantial":[38,358],"need":[39],"other":[41],"approaches":[42],"activating":[44],"cancer":[49,144,278],"immunotherapy.":[50,145],"Inhibition":[51,147],"enzyme":[54],"ENPP1,":[55],"negative":[57],"regulator":[58],"one":[64],"such":[65],"approach.":[66],"ENPP1":[67,95,110,139,196,223],"hydrolyses":[68],"2\u20323\u2032-":[69],"cGAMP":[70],"(endogenous":[71],"agonist)":[73],"negatively":[75],"regulates":[76],"dependent":[78],"immune":[79,117,124],"activation.":[80],"Several":[81],"like":[83,89,158],"human":[84],"astrocyte":[85],"TNBC":[88],"4T1":[90,170,276],"MDA-MB-231":[92],"high":[94],"expression":[96],"which":[97,126],"plays":[98],"key":[100],"role":[101],"in":[102,169,178,188,195,233,239,273,316,338],"tumor":[103,255,359,364],"progression":[104],"blocks":[106],"T":[107],"cell":[108,128],"infiltration.":[109],"not":[111],"only":[112],"abolishes":[113],"mediated":[116],"activation":[118],"but":[119],"also":[120,193],"produces":[121],"adenosine,":[122],"suppressor":[125],"promotes":[127],"migration.":[129],"AVA-NP-695":[130,150,166,187,205,264,284,295,304,321,349,372,392],"highly":[133],"potent":[134,220,368],"orally":[135],"available":[136],"small":[137,221],"molecule":[138,222],"inhibitor":[140,224],"being":[141],"developed":[142],"Methods":[146],"potencies":[148],"were":[151],"confirmed":[152],"by":[153,263,331],"enzymatic":[154],"assays":[155],"using":[156],"substrates":[157],"p-Nitrophenyl-5\u2032-TMP,":[159],"2\u20193\u2019-cGAMP":[160],"ATP.":[162],"The":[163,367],"was":[167,192,206],"demonstrated":[168,290,357],"Tumor":[171],"bearing":[172],"BALB/c":[173,240],"mice":[174],"as":[175,374],"monotherapy":[176,375],"combination":[179,189,201,282,339,347,377],"with":[180,190,204,285,297,340,350,379],"anti-PD-L1,":[181,341],"Olaparib":[182,270,287,342],"Paclitaxel.":[184,298],"Efficacy":[185],"radiation":[191,351],"evaluated":[194,207],"overexpressing":[197],"breast":[198,277,397],"tumors.":[199],"Finally,":[200,346],"PSMA-RLT":[203],"treating":[209],"prostate":[210],"cancer.":[211,398],"Results":[212,248],"We":[213],"demonstrate":[214],"that":[215],"AVA-NP-695,":[216],"selective":[218],"showed":[225,324],"no":[226],"adverse":[227],"effects":[228],"at":[229],"1000":[230],"mg/kg":[231,266],"BID":[232],"14":[234],"day":[235],"repeated":[236],"dose":[237,353],"toxicity":[238],"mice,":[241],"demonstrating":[243],"excellent":[245],"therapeutic":[246,389],"window.":[247],"from":[249],"in-vivo":[250],"studies":[251,403],"shown":[253],"superior":[254],"growth":[256,360],"inhibition":[257],"(TGI)":[258],"impact":[260],"on":[261],"metastasis":[262],"(6":[265],"BID)":[267],"compared":[268],"Anti-PD1":[272],"syngeneic":[275],"mouse":[279],"model.":[280],"Subsequently,":[281],"Anti-PDL1,":[286],"Paclitaxel":[289,302,344],"encouraging":[291],"combinatorial":[292],"along":[296,378],"Monotherapeutic":[299],"arm":[300],"depicted":[305],"40%":[306],"44%":[308],"TGI":[309],"respectively;":[310],"however":[311],"combined":[313],"treatment":[314,322],"resulted":[315],"~60%":[317],"TGI.":[318],"Additionally,":[319],"alone":[323],"50%":[325],"enhanced":[326],"mean":[327],"survival":[328],"time":[329],"followed":[330],"68%,":[332],"68%":[333],"72%":[335],"when":[336],"given":[337],"respectively.":[345],"(Fractionated":[352],"Targeted":[355],"Radionuclide)":[356],"reduction":[361],"across":[362],"various":[363],"models.":[365],"Conclusions":[366],"anti-tumor":[369],"both":[373],"its":[380],"safety":[381],"profile":[382],"provides":[383],"strong":[385],"rationale":[386],"potential":[390],"against":[393],"solids":[394],"tumors,":[395],"particularly":[396],"Ethics":[399],"Approval":[400],"All":[401],"animal":[402],"involved":[404],"obtained":[405],"prerequisite":[407],"ethics":[408],"committee(s)":[409],"approval.":[410]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}